Current Landscape in IBD and Unmet Needs

Program Overview

Advances in inflammatory bowel disease (IBD) treatment have improved outcomes for many patients but personalizing therapy and predicting response to therapy is a huge challenge. This has led to underutilization of effective regimens, undertreatment, and suboptimal outcomes. This activity reviews how new and emerging clinical decision support tools can help providers bridge this gap by predicting individualized disease complication risk and response to therapy.

Credit Expired

CE Credit Expired

Expires: August 29, 2020

Target Audience

This activity is intended for clinicians who manage patients with inflammatory bowel disease (IBD).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Apply novel, predictive decision support tools to stratify patients with inflammatory bowel disease (IBD) based on complication risk and disease severity in order to inform appropriate treatment initiation and timing
Integrate biologics into the treatment regimen for IBD based on individual probability of response to specific biologics
Identify patients with IBD being treated with biologics who require more aggressive treatment approaches, such as combination therapy and treat-to-target monitoring

Activity Faculty

Parambir Dulai, MD (Chair)

Assistant Professor
UC San Diego School of Medicine
San Diego, CA

Joshua Rubin, MD (Co-Chair)

Assistant Clinical Professor
UC San Diego School of Medicine
San Diego, CA

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 